Enhabit at Jefferies Conference: Strategic Moves Amid Medicare Cuts

Enhabit Inc. (NYSE:EHAB) highlighted its strategic initiatives at the Jefferies 2025 Healthcare Services Conference, focusing on mitigating a proposed 6.4% Medicare payment cut, estimated to be a $35-40 million headwind. The company is piloting a Visits Per Episode (VPE) program, projecting $5-8 million in annual savings for each half-visit reduction, and pursuing G&A efficiencies. Concurrently, Enhabit has significantly reduced debt by prepaying $85 million since Q3 2023, cutting annualized interest expenses by over $17 million, and secured a double-digit rate increase from a large national payer through successful episodic contract negotiations. Management expressed confidence in its robust hospice segment growth and its ability to capitalize on potential industry disruption and consolidation arising from the Medicare cuts.

Analysis

Enhabit Inc. (EHAB) is executing a multi-pronged strategy to navigate significant regulatory headwinds while strengthening its fundamental operations. The primary threat is a proposed 6.4% Medicare payment cut, which management quantifies as a $35-40 million unmitigated headwind. To counteract this, the company is piloting an initiative to reduce its Visits Per Episode (VPE) from just under 14 towards the industry average of approximately 12, estimating an annual benefit of $5-8 million for each half-visit reduction. Concurrently, Enhabit is demonstrating strong financial discipline, having prepaid approximately $85 million in debt since Q3 2023, which reduced annualized interest expenses by over $17 million and lowered leverage by a full turn. This improved cash flow is complemented by successful payer negotiations, highlighted by securing a double-digit rate increase from a large national payer and contracting with all major plans. Furthermore, the hospice segment is a key growth driver, benefiting from internal process improvements that have eliminated previous capacity constraints and diversified referral sources. Management's strategy appears focused on creating operational and financial resilience to not only absorb potential rate cuts but also to capitalize on industry consolidation that may result from less-prepared competitors.

Key Decisions for Investors

• Investors should closely monitor Enhabit's upcoming Q3 results for initial data from the 11-branch VPE reduction pilot, as its success is the primary lever to offset the potential $35-40 million Medicare rate headwind.
• Consider the company's improved financial flexibility stemming from its aggressive debt reduction, which has freed up over $17 million in annual cash flow and positions it to either continue deleveraging or strategically pursue market share from distressed peers.
• Evaluate whether the market is fully pricing in the successful payer strategy, including the double-digit rate increase, and the strong, internally-driven growth of the hospice segment, which management believes is underappreciated in a sum-of-the-parts valuation.